Get Premium Data for Cyber Monday: Up to 55% Off InvestingProCLAIM SALE

Pro Medicus Ltd (PME)

Sydney
Currency in AUD
268.10
+0.10(+0.04%)
Closed
PME Scorecard
Full Analysis
Has raised its dividend for 9 consecutive years
Fair Value
Day's Range
263.00269.54
52 wk Range
85.60271.37
Key Statistics
Edit
Bid/Ask
266.47 / 269.46
Prev. Close
268
Open
265.32
Day's Range
263-269.54
52 wk Range
85.6-271.37
Volume
192.48K
Average Volume (3m)
257.34K
1-Year Change
200.63%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PME Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
176.21
Downside
-34.27%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory
Show more

Pro Medicus Ltd Company Profile

Pro Medicus Limited, a healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe. The company offers Visage RIS Visage 7 Enterprise Imaging Platform, a healthcare imaging software that provides radiologists, physicians, and clinicians with access and visualization capability for viewing 2-D, 3-D, and 4-D medical images; and picture archive and communication system (PACS)/digital imaging software. It also provides Visage RIS, a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; Promedicus.net, an e-health platform for secure email and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company was incorporated in 1983 and is headquartered in Richmond, Australia.

Compare PME to Peers and Sector

Metrics to compare
PME
Peers
Sector
Relationship
P/E Ratio
338.4x−4.4x−0.7x
PEG Ratio
9.30−0.030.00
Price/Book
149.2x1.5x2.6x
Price / LTM Sales
173.5x2.7x3.2x
Upside (Analyst Target)
−37.6%66.7%46.6%
Fair Value Upside
Unlock11.1%7.4%Unlock

Analysts' Recommendations

3 Buy
9 Hold
2 Sell
Ratings:
14 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 176.21

(-34.28% Downside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.793
Dividend Yield
0.15%
Industry Median 1.21%
Annualized payout
0.4000
Paid unevenly
5-Years Growth
+37.97%
Growth Streak

People Also Watch

131.37
WTC
-0.49%
253.63
CEG
-0.96%
401.50
APP
+5.92%
517.37
IT
+0.15%
251.43
REA
-1.38%

FAQ

What Is the Pro Medicus Ltd (PME) Stock Price Today?

The Pro Medicus Ltd stock price today is 268.10

What Stock Exchange Does Pro Medicus Ltd Trade On?

Pro Medicus Ltd is listed and trades on the Sydney stock exchange.

What Is the Stock Symbol for Pro Medicus Ltd?

The stock symbol for Pro Medicus Ltd is "PME."

Does Pro Medicus Ltd Pay Dividends? What’s The Current Dividend Yield?

The Pro Medicus Ltd dividend yield is 0.15%.

What Is the Pro Medicus Ltd Market Cap?

As of today, Pro Medicus Ltd market cap is 28.02B.

What is Pro Medicus Ltd Earnings Per Share?

The Pro Medicus Ltd EPS is 0.793.

What Is the Next Pro Medicus Ltd Earnings Date?

Pro Medicus Ltd will release its next earnings report on Feb 17, 2025.

From a Technical Analysis Perspective, Is PME a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.